PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 22996291-2 2013 Zoledronic acid (ZA) is a bisphosphonate known to upregulate the expression of TRAIL on human gammadelta T cells. Diphosphonates 26-40 TNF superfamily member 10 Homo sapiens 79-84 30120241-0 2018 Author Correction: Bisphosphonate enhances TRAIL sensitivity to human osteosarcoma cells via death receptor 5 upregulation. Diphosphonates 19-33 TNF superfamily member 10 Homo sapiens 43-48 19577359-7 2010 In conclusion, zoledronic acid enhanced the TRAIL-to-OPG ratio in TRAIL-sensitive MDA-MB-231 cells, indicating that the TRAIL/OPG cytokine system is a bisphosphonate-responsive target in breast cancer. Diphosphonates 151-165 TNF superfamily member 10 Homo sapiens 44-49 21297379-0 2011 Bisphosphonate enhances TRAIL sensitivity to human osteosarcoma cells via death receptor 5 upregulation. Diphosphonates 0-14 TNF superfamily member 10 Homo sapiens 24-29 21297379-4 2011 The purpose of this study was to determine the effects of bisphosphonates on TRAIL-resistant MG 63 human osteosarcoma cells. Diphosphonates 58-73 TNF superfamily member 10 Homo sapiens 77-82 21297379-5 2011 The cells showed no response to TRAIL alone; however, pre-treatment with bisphosphonates significantly increased TRAIL-mediated apoptosis and cellular activation of caspase-3. Diphosphonates 73-88 TNF superfamily member 10 Homo sapiens 113-118 21297379-6 2011 Bisphosphonates significantly induced mRNA and protein expression of the TRAIL receptor, DR5. Diphosphonates 0-15 TNF superfamily member 10 Homo sapiens 73-78 21297379-7 2011 Bisphosphonates induced protein unprenylation in MG 63 cells; in addition, co-treatment with TRAIL also significantly increased protein unprenylation. Diphosphonates 0-15 TNF superfamily member 10 Homo sapiens 93-98 21297379-9 2011 This is the first study to demonstrate that bisphosphonates markedly enhanced TRAIL-induced apoptosis in human osteosarcoma cells. Diphosphonates 44-59 TNF superfamily member 10 Homo sapiens 78-83 21297379-10 2011 These findings suggest that bisphosphonates may be a new and effective anticancer treatment with TRAIL proteins for TRAIL-resistant cancer cells. Diphosphonates 28-43 TNF superfamily member 10 Homo sapiens 97-102 21297379-10 2011 These findings suggest that bisphosphonates may be a new and effective anticancer treatment with TRAIL proteins for TRAIL-resistant cancer cells. Diphosphonates 28-43 TNF superfamily member 10 Homo sapiens 116-121 19577359-7 2010 In conclusion, zoledronic acid enhanced the TRAIL-to-OPG ratio in TRAIL-sensitive MDA-MB-231 cells, indicating that the TRAIL/OPG cytokine system is a bisphosphonate-responsive target in breast cancer. Diphosphonates 151-165 TNF superfamily member 10 Homo sapiens 66-71 19577359-7 2010 In conclusion, zoledronic acid enhanced the TRAIL-to-OPG ratio in TRAIL-sensitive MDA-MB-231 cells, indicating that the TRAIL/OPG cytokine system is a bisphosphonate-responsive target in breast cancer. Diphosphonates 151-165 TNF superfamily member 10 Homo sapiens 66-71